GPCR
Structure Therapeutics Inc.Company Information
- Company Name
- Structure Therapeutics Inc.
- CIK
- CIK0001888886
- Category
- Large accelerated filer
- Ticker: Exchange
- GPCR: Nasdaq
- Fiscal Year End
- December 31
- Owner Organization
- 03 Life Sciences
- SIC
- 2834
- SIC Description
- Pharmaceutical Preparations
- Ticker
- GPCR
SEC filing data through
Insider Sentiment
- Last purchase
- —
- Last sale
- —
- Shares purchased (TTM)
- 0
- Shares sold (TTM)
- 0
Institutional Sentiment
- As of
- 2026-06-30
- Institutional shares owned
- 66,304,823
- Shares outstanding
- 72,652,333
- Ownership
- 91.26%
Earnings Market Reaction
- Filing date
- 2026-08-06
- Price on filing date
- —
- 1-month reaction
- -9.98%
- 3-month reaction
- …
Balance Sheet
Values in millions ($)| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Trend |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Assets Current | ||||||||||||||||||
| Cash And Cash Equivalents At Carrying Value | 273 | 316 | 800 | 103 | 147 | 152 | 170 | 172 | 382 | 98 | 130 | 51 | ||||||
| Short Term Investments | 1,070 | 1,142 | 647 | 696 | 639 | 685 | 714 | 743 | 545 | 339 | 338 | 155 | ||||||
| Other Receivables Net Current | - | - | 100 | - | - | - | - | - | - | - | - | - | ||||||
| Prepaid Expense And Other Assets Current | 29 | 32 | 24 | 15 | 13 | 13 | 8 | 8 | 11 | 13 | 6 | 5 | ||||||
| Assets Current | 1,372 | 1,491 | 1,570 | 814 | 799 | 850 | 891 | 924 | 938 | 449 | 474 | 210 | ||||||
| Property Plant And Equipment Net | 6 | 6 | 7 | 5 | 3 | 4 | 3 | 4 | 3 | 3 | 3 | 2 | ||||||
| Operating Lease Right Of Use Asset | 6 | 6 | 6 | 7 | 7 | 7 | 4 | 4 | 4 | 5 | 5 | 4 | ||||||
| Other Assets Noncurrent | 41 | 6 | 1 | 7 | 6 | 6 | 5 | 2 | 2 | 0 | 0 | 0 | ||||||
| Assets | 1,425 | 1,508 | 1,584 | 832 | 816 | 867 | 903 | 933 | 947 | 457 | 482 | 216 | ||||||
Liabilities Current | ||||||||||||||||||
| Accounts Payable Current | 11 | 8 | 14 | 18 | 9 | 9 | 8 | 8 | 2 | 7 | 5 | 3 | ||||||
| Operating Lease Liability Current | 3 | 3 | 3 | 3 | 3 | 2 | 2 | 2 | 2 | 2 | 1 | 1 | ||||||
| Liabilities Current | 66 | 57 | 63 | 58 | 39 | 36 | 36 | 33 | 23 | 24 | 25 | 20 | ||||||
| Operating Lease Liability Noncurrent | 4 | 3 | 4 | 4 | 5 | 5 | 2 | 3 | 3 | 4 | 4 | 3 | ||||||
| Other Liabilities Noncurrent | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Liabilities | 71 | 61 | 68 | 62 | 44 | 42 | 38 | 36 | 26 | 27 | 29 | 23 | ||||||
Stockholders Equity | ||||||||||||||||||
| Common Stock Value | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | - | ||||||
| Additional Paid In Capital | 2,010 | 1,996 | 1,986 | 1,272 | 1,209 | 1,200 | 1,193 | 1,187 | 1,180 | 663 | 659 | 375 | ||||||
| Temporary Equity Carrying Amount Attributable To Parent | - | - | - | - | - | - | - | - | - | - | 0 | - | ||||||
| Accumulated Other Comprehensive Income Loss Net Of Tax | -3 | -2 | 1 | 1 | 0 | 1 | 1 | 3 | -0 | -0 | 1 | -0 | ||||||
| Retained Earnings Accumulated Deficit | -652 | -546 | -470 | -503 | -438 | -376 | -329 | -293 | -259 | -233 | -207 | -182 | ||||||
| Stockholders Equity | 1,354 | 1,447 | 1,516 | 770 | 772 | 825 | 865 | 897 | 921 | 430 | 453 | 193 | ||||||
| Liabilities And Stockholders Equity | 1,425 | 1,508 | 1,584 | 832 | 816 | 867 | 903 | 933 | 947 | 457 | 482 | 216 | ||||||
| Preferred Stock Par Or Stated Value Per Share | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ||||||
| Preferred Stock Shares Authorized | 33 | 33 | 33 | 33 | 33 | 33 | 33 | 33 | 33 | 30 | 33 | 33 | ||||||
| Common Stock Par Or Stated Value Per Share | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | - | ||||||
| Common Stock Shares Authorized | 167 | 167 | 167 | 167 | 167 | 167 | 167 | 167 | 167 | 167 | 167 | - | ||||||
| Common Stock Shares Issued | 71 | 71 | 71 | 61 | 58 | 58 | 57 | 57 | 57 | 47 | 46 | - | ||||||
| Shares Outstanding | 71 | 71 | 71 | 61 | 58 | 58 | 57 | 57 | 57 | 47 | 46 | - | ||||||
| Series Redeemable Convertible Preferred Shares | - | - | - | - | - | - | - | - | - | - | 0 | 0 | ||||||
| Series Plus Redeemable Convertible Preferred Shares | - | - | - | - | - | - | - | - | - | - | 0 | 0 | ||||||
| Series B Redeemable Convertible Preferred Stock | - | - | - | - | - | - | - | - | - | - | 0 | 0 | ||||||
| Series B One Redeemable Convertible Preferred Stock | - | - | - | - | - | - | - | - | - | - | 0 | 0 | ||||||
| Non Voting Ordinary Shares | - | - | - | - | - | - | - | - | - | - | - | 0 | ||||||
| Ordinary Shares | - | - | - | - | - | - | - | - | - | - | 139 | 0 | ||||||
Select a line item above to chart it.
Recent filings
- 10-QFiled
- 10-QFiled
- 10-KFiled
- 10-QFiled
- 10-QFiled
- 10-QFiled
- 10-KFiled
- 10-QFiled
- 10-QFiled
- 10-QFiled
- 10-KFiled
- 10-QFiled
Financial statements beyond 3 years are for subscribers only.
Unlock 17+ years of income statements, balance sheets, and cash flow statements
Start 7-day free trialStructure Therapeutics Inc. (GPCR) — SEC Financial Statements & Analysis
Structure Therapeutics Inc. (GPCR) is a pharmaceutical preparations company, incorporated in E9. Structure Therapeutics Inc. trades on Nasdaq as: GPCR. Structure Therapeutics Inc. (GPCR)'s most recent SEC filing is a Form 10-Q for the period ended 2026-06-30, filed with the SEC on 2026-08-06. Based on that filing, Structure Therapeutics Inc. carries a market cap of $3.90B, a P/E ratio of -18.15x, a P/B ratio of 2.88x, an enterprise value of $3.63B, and an EV/EBITDA multiple of -14.17x. On profitability, it posts a Return on Equity (ROE) of -20.21%, a Return on Assets (ROA) of -19.17%, and a Return on Invested Capital (ROIC) of -30.21%. Per share, it reports EPS of $-2.96, diluted EPS of $-2.96, free cash flow per share of $-3.09, and a dividend per share of $0.00. Over the trailing year, it posted net income growth of 20.05% year-over-year and EPS growth of -4.90% year-over-year. On the balance sheet, it maintains a current ratio of 20.75x, a quick ratio of 20.31x, working capital of $1.31B, a debt-to-equity ratio of 0.05x, a debt ratio of 0.05, free cash flow of $-224.59M (TTM), and net debt of $-272.64M. Figures sourced from SEC EDGAR.
- Market Cap
- $3.90B
- P/E TTM
- -18.15x
- EPS TTM
- $-2.96
- P/B TTM
- 2.88x
- ROE TTM
- -20.21%
- ROA TTM
- -19.17%
- Debt To Equity
- 0.05x
- Free Cash Flow TTM
- $-224.59M
Data as of 2026-06-30 · Source: SEC EDGAR
Frequently Asked Questions
What industry is Structure Therapeutics Inc. in?
Structure Therapeutics Inc. (GPCR) operates in the Pharmaceutical Preparations industry.
What exchange does GPCR trade on?
Structure Therapeutics Inc. (GPCR) trades on the Nasdaq.
Where is Structure Therapeutics Inc. incorporated?
Structure Therapeutics Inc. is incorporated in Cayman Islands.
When was Structure Therapeutics Inc. (GPCR)'s most recent SEC filing?
Structure Therapeutics Inc. (GPCR)'s most recent SEC filing is a Form 10-Q for the period ended 2026-06-30, filed with the SEC on 2026-08-06.
What is GPCR's market cap?
Structure Therapeutics Inc. (GPCR) has a market capitalization of $3.90B as of 2026-06-30.
What is GPCR's EPS (earnings per share)?
Structure Therapeutics Inc. (GPCR)'s trailing twelve month EPS is $-2.96 as of 2026-06-30.
What is GPCR's ROE (return on equity)?
Structure Therapeutics Inc. (GPCR)'s trailing twelve month Return on Equity (ROE) is -20.21% as of 2026-06-30.
What is GPCR's ROA (return on assets)?
Structure Therapeutics Inc. (GPCR)'s trailing twelve month Return on Assets (ROA) is -19.17% as of 2026-06-30.
What is GPCR's ROIC (return on invested capital)?
Structure Therapeutics Inc. (GPCR)'s trailing twelve month Return on Invested Capital (ROIC) is -30.21% as of 2026-06-30.
What is GPCR's EV/EBITDA?
Structure Therapeutics Inc. (GPCR)'s trailing twelve month EV/EBITDA is -14.17x as of 2026-06-30.